Person-centered medicine versus personalized medicine: Is it just a sophism? A view from chronic pain management

Psychiatria Danubina

Volumn 23, Issue 3, 2011, Pages 246-250

  Braš, Marijana ^a   Dordević, Veljko ^a   Milunović, Vibor ^a   Brajković, Lovorka ^a   Miličić, Davor ^a   Konopka, Lukasz ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b THE CHICAGO SCHOOL OF PROFESSIONAL PSYCHOLOGY   (United States)

Author keywords

Chronic pain; Fibromyalgia; Patient centered medicine; Personalized medicine

Indexed keywords

AMITRIPTYLINE; BIOLOGICAL MARKER; DULOXETINE; FLUOXETINE; MILNACIPRAN; PREGABALIN; TRAMADOL;

CHRONIC PAIN; CONCEPT ANALYSIS; DRUG USE; ENDOPHENOTYPE; EPIGENETICS; FIBROMYALGIA; HUMAN; OUTCOMES RESEARCH; PAIN ASSESSMENT; PATIENT CARE; PERSON CENTERED MEDICINE; PERSONALIZED MEDICINE; PHENOMENOLOGY; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

CHRONIC DISEASE; COMPLEMENTARY THERAPIES; FIBROMYALGIA; HUMANS; INDIVIDUALIZED MEDICINE; PAIN; PAIN MANAGEMENT; PATIENT-CENTERED CARE;

EID: 80054095262     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Bangert AS, Glass JM, Welsh RC, Crofford LJ, Taylor SF& Park DC. Functional magnetic resonance imaging of working memory in fibromyalgia. Arthritis Rheum. 2003; 48:S90.
2. Barnes J. The Cambridge companion to Aristotle. Cambridge University Press, 1995.
3. Bazzichi L, Rossi A, Giacomelli C & Bombardieri S. Exploring the abyss of fibromyalgia biomarkers. Clin Exp Rheumatol. 2010; 28: S125-30.
4. Burckhardt CS, Clark SR, Bennett RM.: The fibromyalgia impact questionnaire (FIQ): development and validation. J Rheumatol. 1991; 18:728-733.
5. Burckhardt CS, Goldenberg D, Crofford L, Gerwin R, Gowans S, Kackson, et al. Guideline for the management of fibromyalgia syndrome. Pain in adults and children. APS Clinical Practice Guideline Series No. 4. Glenview, IL: American Pain Society; 2005.
6. Carville SF, Arendt-Nielsen S, Bliddal H, Blotman F, Branco JC, Buskila D, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008; 67:536-41. (Pubitemid 351498437)
7. Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore. 1994; 23:129-38.
8. Farrell MJ, VanMeter JW, Petzke F, Wolfe JM, Grant MAB, Clauw DJ & Gracely RH. Supraspinal activity associated with painful pressure in fibromyalgia is associated with beliefs about locus of pain control Arthritis Rheum. 2001; 44:S394.
9. Felce D & Perry J. Quality of life: its definition and measurement. Res Dev Disabil. 1995; 16:51-74.
10. Gracely RH, Geisser ME, Giesecke T, Grant MA, Petzke F, Williams DA & Clauw DJ. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain. 2004; 127:835-43. (Pubitemid 38478528)
11. Gran JT. The epidemiology of chronic generalized musculoskeletal pain. Best Pract Res Clin Rheumatol. 2003; 17:547-61.
12. Häuser W, Thieme K & Turk DC. Guidelines on the management of fibromyalgia syndrome - a systematic review. Eur J Pain. 2010; 14: 5-10.
13. IASP Task Force on Taxonomy. Part III: Pain Terms, A Current List with Definitions and Notes on Usage in Merskey H. and Bogduk N. Eds. "Classification of Chronic Pain, Second Edition" IASP Press, Seattle. 1994 pp 209-214.
14. Jakovljević M: Integrating brave new psychiatry of the person, for the person, by the person and with the person: The postmodern turn. Psychiatria Danubina 2008; 20:2-5.
15. Jakovljević M, Reiner Z, Milicić D & Crncević Z. Comorbidity, multimorbidity and personalized psychosomatic medicine: epigenetics rolling on the horizon. Psychiatria Danubina 2010; 22:184-9.
16. Jakovljević M. The creative psychopharmacotherapy and personalized medicine: The art & practice of the learning organization. Psychiatr Danub. 2010; 22:309-12.
17. Klement A, Häuser W, Brückte W, Eidmann U, Felde E, Herrmann M, et al. Allgemeine Behandlungsgrundsätze, Versorgungskoordination und Patientenschulung beim Fibromyalgiesyndrom und chronischen Schmerzen in mehreren Körperregionen (General principles of therapy, coordination of medical care and patient education in fibromyalgia syndrome and chronic widespread pain). Schmerz 2008; 22:283-94.
18. Melzack R. Pain and the neuromatrix in the brain. J Dent Educ 2001; 65:1378-1382.
19. Mezzich JE, Snaedal J, van Weel C, Botbol M, Salloum I. Introduction to person-centred medicine: from concepts to practice. J Eval Clin Pract. 2011; 17:330-2.
20. Salloum IM & Mezzich JE. Person-centered diagnosis. Int J Integr Care. 2010; 10:e027.
21. Saunders C.M. 1978 The Management of Terminal Disease. Arnold Recla JM. New and emerging therapeutic agents for the treatment of fibromyalgia: an update. J Pain Res. 2010 Jul 22; 3:89-103.
22. Usui C, Hatta K, Doi N, Nakanishi A, Nakamura H, Nishioka K & Arai H Brain perfusion in fibromyalgia patients and its differences between responders and poor responders to gabapentin. Arthritis Res Ther. 2010; 12:R64.
23. Williams DA & Gracely RH. Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia. Arthritis Res Ther. 2006; 8:224.
24. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990. Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33:160-72. (Pubitemid 20098653)
25. Wolfe F. Stop using the American College of Rheumatology criteria in the clinic. J Rheumatol. 2003; 30:1671-2. (Pubitemid 36962441)
26. Wolfe F, Clauw DJ Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB & Yunus MB. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 2010; 62: 600-10.